| Balance Sheet of Zydus Lifesciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
100.60 |
100.60 |
101.20 |
102.40 |
102.40 |
|
| Total Share Capital |
100.60 |
100.60 |
101.20 |
102.40 |
102.40 |
|
| Reserves and Surplus |
21,089.50 |
15,615.90 |
13,538.20 |
13,138.10 |
12,642.10 |
|
| Total Reserves and Surplus |
21,089.50 |
15,615.90 |
13,538.20 |
13,138.10 |
12,642.10 |
|
| Total Shareholders Funds |
21,190.10 |
15,716.50 |
13,639.40 |
13,240.50 |
12,744.50 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
2,862.10 |
5,555.40 |
3,771.00 |
126.40 |
609.50 |
|
| Deferred Tax Liabilities [Net] |
145.60 |
58.30 |
194.30 |
153.10 |
107.30 |
|
| Other Long Term Liabilities |
30.80 |
28.10 |
21.70 |
15.70 |
12.80 |
|
| Long Term Provisions |
236.90 |
185.10 |
147.10 |
176.40 |
168.50 |
|
| Total Non-Current Liabilities |
3,275.40 |
5,826.90 |
4,134.10 |
471.60 |
898.10 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
5,476.60 |
618.10 |
1,051.50 |
2,536.20 |
3,306.40 |
|
| Trade Payables |
1,231.60 |
1,111.80 |
1,043.20 |
1,065.20 |
1,126.00 |
|
| Other Current Liabilities |
1,025.30 |
706.10 |
604.00 |
343.80 |
322.00 |
|
| Short Term Provisions |
117.90 |
105.40 |
91.40 |
82.70 |
66.60 |
|
| Total Current Liabilities |
7,851.40 |
2,541.40 |
2,790.10 |
4,027.90 |
4,821.00 |
|
| Total Capital And Liabilities |
32,316.90 |
24,084.80 |
20,563.60 |
17,740.00 |
18,463.60 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
4,135.80 |
4,325.70 |
4,141.80 |
4,296.60 |
4,064.50 |
|
| Intangible Assets |
66.30 |
43.70 |
42.30 |
39.30 |
47.50 |
|
| Capital Work-In-Progress |
1,188.50 |
626.70 |
739.30 |
384.00 |
570.50 |
|
| Other Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Fixed Assets |
5,390.60 |
5,003.30 |
4,923.40 |
4,719.90 |
4,682.50 |
|
| Non-Current Investments |
7,255.00 |
7,283.00 |
4,677.70 |
4,897.50 |
6,470.60 |
|
| Deferred Tax Assets [Net] |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Long Term Loans And Advances |
4,119.00 |
3,640.60 |
3,165.80 |
917.80 |
912.70 |
|
| Other Non-Current Assets |
237.60 |
222.10 |
638.50 |
367.40 |
366.10 |
|
| Total Non-Current Assets |
17,002.20 |
16,149.00 |
13,405.40 |
10,902.60 |
12,431.90 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
4,236.50 |
0.00 |
201.60 |
220.50 |
0.00 |
|
| Inventories |
1,952.10 |
1,687.30 |
1,782.40 |
1,926.30 |
1,780.00 |
|
| Trade Receivables |
8,161.80 |
4,740.10 |
3,505.30 |
2,277.70 |
1,903.80 |
|
| Cash And Cash Equivalents |
144.10 |
414.40 |
248.10 |
302.60 |
154.00 |
|
| Short Term Loans And Advances |
125.10 |
104.80 |
817.00 |
1,476.30 |
1,435.80 |
|
| OtherCurrentAssets |
695.10 |
989.20 |
603.80 |
634.00 |
758.10 |
|
| Total Current Assets |
15,314.70 |
7,935.80 |
7,158.20 |
6,837.40 |
6,031.70 |
|
| Total Assets |
32,316.90 |
24,084.80 |
20,563.60 |
17,740.00 |
18,463.60 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
1,737.70 |
1,750.30 |
752.40 |
2,233.10 |
2,009.30 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
|
|
| Raw Materials |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| Expenditure In Foreign Currency |
2,488.70 |
1,927.40 |
2,054.40 |
2,186.90 |
1,591.10 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
|
|
| Dividend Remittance In Foreign Currency |
-- |
-- |
-- |
-- |
-- |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| FOB Value Of Goods |
10,579.30 |
8,411.70 |
6,757.70 |
6,306.50 |
6,353.50 |
|
| Other Earnings |
-- |
-- |
-- |
-- |
-- |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
72.97 |
72.97 |
72.97 |
72.97 |
72.97 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
6,489.40 |
5,732.20 |
6,020.50 |
5,859.60 |
7,320.70 |
|
| Non-Current Investments Unquoted Book Value |
5,692.20 |
5,726.60 |
3,106.60 |
3,307.30 |
5,143.20 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
